Brand Name | Status | Last Update |
---|---|---|
atarax | 2006-06-20 | |
hydoxyzine pamoate | ANDA | 2010-12-30 |
hydroxyzine | ANDA | 2024-08-05 |
hydroxyzine dihydrochloride | ANDA | 2024-07-16 |
hydroxyzine hcl | ANDA | 2024-09-13 |
hydroxyzine hcl hydroxyzine hydrochloride | ANDA | 2023-04-13 |
hydroxyzine hydrochloride | ANDA | 2025-08-18 |
hydroxyzine hydrochloride hydroxyzine hydrochloride | ANDA | 2021-01-25 |
hydroxyzine pamoate | ANDA | 2025-08-07 |
mkh dose pack | unapproved drug other | 2019-03-05 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
substance withdrawal syndrome | EFO_0005800 | D013375 | — |
pruritus | — | D011537 | L29 |
vomiting | — | D014839 | R11.1 |
nausea | — | D009325 | R11.0 |
anxiety disorders | EFO_0006788 | D001008 | F41.1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 2 | — | — | — | — | 2 |
Drug common name | Hydroxyzine |
INN | hydroxyzine |
Description | Hydroxyzine is a N-alkylpiperazine that is piperzine in which the nitrogens atoms are substituted by 2-(2-hydroxyethoxy)ethyl and (4-chlorophenyl)(phenyl)methyl groups respectively. It has a role as a H1-receptor antagonist, an anxiolytic drug, a dermatologic drug, an antipruritic drug and an anticoronaviral agent. It is a N-alkylpiperazine, a hydroxyether and a member of monochlorobenzenes. |
Classification | Small molecule |
Drug class | First generation antihistamine |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | OCCOCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1 |
PDB | — |
CAS-ID | 68-88-2 |
RxCUI | — |
ChEMBL ID | CHEMBL896 |
ChEBI ID | 5818 |
PubChem CID | 3658 |
DrugBank | DB00557 |
UNII ID | 30S50YM8OG (ChemIDplus, GSRS) |